Metocard Tablets 50mg – Effective Treatment for Hypertension, Angina, and Arrhythmia
Description:
Metocard tablets 50mg offer a reliable and effective solution for various cardiovascular conditions, including hypertension, angina pectoris, and arrhythmias. Each blister pack contains 10 tablets, with a convenient 3-pack for a longer supply.
Active Ingredient:
The primary active ingredient in Metocard is metoprolol tartrate, a beta1-adrenergic blocker. It effectively reduces blood pressure, alleviates angina attacks, and controls irregular heart rhythms.
Key Features & Benefits:
- Cardioselective beta1-adrenergic blocker: Targets the heart, minimizing side effects on other organs.
- Antihypertensive, antianginal, and antiarrhythmic effects: Controls high blood pressure, relieves chest pain, and stabilizes heart rhythm.
- Effective for various conditions: Suitable for hypertension, angina pectoris, supraventricular tachycardia, ventricular extrasystole, and hyperthyroidism.
- Convenient dosage: Available in 50mg tablets for easy administration.
- Blister packaging: Ensures safe and hygienic storage of tablets.
- Available in 3-pack: Provides a convenient and economical option for longer use.
Important Information:
- Consult a doctor: Always consult your healthcare professional before taking Metocard, especially if you have any existing medical conditions or are taking other medications.
- Individualized dosage: The recommended dose and frequency of administration should be determined by your doctor based on your individual needs and medical history.
- Potential side effects: Like any medication, Metocard may cause side effects. It’s important to be aware of these and seek medical attention if any occur.
- Drug interactions: Inform your doctor about all other medications you are taking to avoid potential interactions.
- Pregnancy and lactation: Metocard should only be used during pregnancy under strict medical supervision. It is not recommended for breastfeeding mothers.
Find Out More:
For complete product information, including detailed instructions, dosage recommendations, precautions, and potential side effects, please consult your doctor or pharmacist.
Buy Metocard Tablets 50mg No. 10×3:
Ensure you are obtaining Metocard from a reputable source. Contact your local pharmacy or healthcare provider to inquire about purchasing this medication.
Note: This text provides general information about Metocard tablets 50mg and should not be considered medical advice. Always consult your doctor or pharmacist for personalized recommendations.
| INN | METOPROLOL |
|---|---|
| The code | 3 353 |
| Barcode | 5 903 060 005 358 |
| Dosage | 50mg |
| Active substance | Metoprolol tartrate |
| Manufacturer | Pharm.z-d Polpharma SA, Poland |
| Indications Applications | arterial hypertension (including hyperkinetic type) as monotherapy or in combination with other antihypertensive agents; IHD: myocardial infarction (secondary prevention – complex therapy), prevention of angina attacks; heart rhythm disturbances (supraventricular tachycardia, ventricular extrasystole); hyperthyroidism (complex therapy); prevention of migraine attacks. |
| Contraindications | cardiogenic shock; AV block II or III degree; sinoatrial blockade; SSSU; severe bradycardia; chronic heart failure in the phase of decompensation; Prinzmetal's angina; arterial hypotension (in the case of use in the secondary prevention of myocardial infarction – systolic blood pressure less than 100 mm Hg, heart rate less than 45 beats / min); lactation period; simultaneous reception with MAO inhibitors; simultaneous intravenous administration of verapamil; age up to 18 years; hypersensitivity to metoprolol or other components of the drug, other beta-blockers. With caution, the drug should be prescribed for diabetes mellitus, metabolic acidosis, bronchial asthma, chronic obstructive pulmonary disease (pulmonary emphysema, chronic obstructive bronchitis), obliterating peripheral vascular diseases (intermittent claudication, Raynaud's syndrome), chronic liver and / or kidney failure, myasthenia gravis, pheochromocytoma, AV blockade of the 1st degree, thyrotoxicosis, depression (including history), psoriasis, pregnancy, as well as elderly patients. |
| Side effects | From the side of the central nervous system and peripheral nervous system: increased fatigue, weakness, headache, slowing down the rate of mental and motor reactions; rarely – paresthesia in the limbs (in patients with intermittent claudication and Raynaud's syndrome), depression, anxiety, decreased attention, drowsiness, insomnia, nightmares, confusion or short-term memory impairment, muscle weakness. From the sensory organs: rarely – decreased vision, decreased secretion of lacrimal fluid, dryness and soreness of the eyes, conjunctivitis, tinnitus. From the side of the cardiovascular system: sinus bradycardia, palpitations, decreased blood pressure, orthostatic hypotension, dizziness, sometimes loss of consciousness; rarely – a decrease in myocardial contractility, a temporary aggravation of symptoms of chronic heart failure (edema, swelling of the feet and / or lower legs, shortness of breath), arrhythmias, manifestation of angiospasm (increased peripheral circulatory disorders, coldness of the lower extremities, Raynaud's syndrome), myocardial conduction disturbance. From the digestive system: nausea, vomiting, abdominal pain, dry mouth, diarrhea, constipation, change in taste, impaired liver function, increased activity of liver enzymes; extremely rarely – hyperbilirubinemia. Dermatological reactions: urticaria, pruritus, rash, exacerbation of psoriasis, psoriasis-like skin reactions, skin flushing, exanthema, photodermatosis, increased sweating, reversible alopecia. On the part of the respiratory system: nasal congestion, difficulty exhaling (bronchospasm when administered in high doses – loss of selectivity and / or in predisposed patients), shortness of breath. From the endocrine system: hyperglycemia in patients with non-insulin dependent diabetes mellitus, hypothyroidism. From the hemopoietic system: rarely – thrombocytopenia (unusual bleeding and hemorrhage), agranulocytosis, leukopenia. Impact on the fetus: possible intrauterine growth retardation, hypoglycemia, bradycardia. Other: back or joint pain; in isolated cases – a slight increase in body weight, a decrease in libido and / or potency. Side effects depend on the individual sensitivity of the patient. Usually they are minor and disappear after the drug is discontinued. |
| Use during pregnancy and lactation | Forbidden to use |
| Age category | 18+ |
| Application Gender | Any |
| Release Form | tablets |
| Main Active Substances | metoprolol tartrate |
| Composition Means | metoprolol tartrate 50 mg Excipients: lactose, povidone, talc, magnesium stearate, microcrystalline cellulose, rice starch. |
| Importer | IOOO Interfarmaks 223028 Minsk region, Minsk district, Zhdanovichsky s / s, ag. Zhdanovichi, st. Star, 19a-5, room. 5-2 |
Related products
